Flecainide in Amyotrophic Lateral Sclerosis as a Neuroprotective Strategy (FANS): A Randomized Placebo-Controlled Trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Flecainide in Amyotrophic Lateral Sclerosis as a Neuroprotective Strategy (FANS): A Randomized Placebo-Controlled Trial

Published:2015-12 Issue:12 Volume:2 Page:1916-1922
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Park Susanna B.,Vucic Steve,Cheah Benjamin C.,Lin Cindy S.-Y.,Kirby Adrienne,Mann Kristy P.,Zoing Margie C.,Winhammar Jennica,Kiernan Matthew C.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference37 articles.

1. Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation;Aliot;Europace,2011

2. Axonal protection in experimental autoimmune neuritis by the sodium channel blocking agent flecainide;Bechtold;Brain,2005

3. Riluzole specifically blocks inactivated Na+ channels in myelinated nerve fibre;Benoit;Pflugers Arch.,1991

4. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis;Brooks;Amyotroph. Lateral Scler. Other Mot. Neuron Disord.,2000

5. The ALSFRS-R: a revised als functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III);Cedarbaum;J. Neurol. Sci.,1999

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging concepts and therapies for amyotrophic lateral sclerosis;Current Opinion in Neurology;2024-09-05

2. Abnormalities of cortical stimulation strength-duration time constant in amyotrophic lateral sclerosis;Clinical Neurophysiology;2024-08

3. Neurophysiological and imaging biomarkers of lower motor neuron dysfunction in motor neuron diseases/amyotrophic lateral sclerosis: IFCN handbook chapter;Clinical Neurophysiology;2024-06

4. Revisiting distinct nerve excitability patterns in patients with amyotrophic lateral sclerosis;Brain;2024-04-25

5. How do we get from hyperexcitability to excitotoxicity in amyotrophic lateral sclerosis?;Brain;2024-02-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3